NAUT - Nautilus Biotechnology - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NAUT is currently covered by 1 analysts with an average price target of $4. This is a potential upside of $1.41 (296.04%) from yesterday's end of day stock price of $1.01.

Nautilus Biotechnology's activity chart (see below) currently has 15 price targets and 16 ratings on display. The stock rating distribution of NAUT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 18.57% with an average time for these price targets to be met of 157.71 days.

Highest price target for NAUT is $4, Lowest price target is $4, average price target is $4.

Most recent stock forecast was given by from GUGGENHEIM on 27-Feb-2026. First documented stock forecast 13-Jul-2021.

Best performing analysts who are covering NAUT - Nautilus Biotechnology:

Matthew Sykes Tejas Savant Brandon Couillard Subbu Nambi

Currently out of the existing stock ratings of NAUT, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Jun-2024

$4

$2 (100.00%)

5 months 8 days ago
(27-Feb-2026)

0/2 (0%)

$1.58 (65.29%)

Hold Since 07-Jan-2022

$3

$1 (50.00%)

$6

1 years 4 months 22 days ago
(13-Mar-2025)

1/4 (25%)

$1.94 (183.02%)

372

Hold Since 04-Aug-2021

$1.75

$-0.25 (-12.50%)

1 years 7 months 30 days ago
(05-Dec-2024)

2/5 (40%)

$-0.17 (-8.85%)

180

Buy Since 13-Jul-2021

$13

$10.05 (340.68%)

5 years 22 days ago
(13-Jul-2021)

0/1 (0%)

$3.2 (32.65%)

Show more analysts

Please expand the browser size to see the chart

What is NAUT (Nautilus Biotechnology) average time for price targets to be met?

On average it took 157.71 days on average for the stock forecasts to be realized with a an average price target met ratio 18.57

Which analyst has the current highest performing score on NAUT (Nautilus Biotechnology) with a proven track record?

MATTHEW SYKES

Which analyst has the current lower performing score on NAUT (Nautilus Biotechnology) with a proven track record?

SUBBU NAMBI

Which analyst has the most public recommendations on NAUT (Nautilus Biotechnology)?

Matthew Sykes works at GOLDMAN SACHS and has 6 price targets and 5 ratings on NAUT

Which analyst is the currently most bullish on NAUT (Nautilus Biotechnology)?

Brandon Couillard with highest potential upside - $10.05

Which analyst is the currently most reserved on NAUT (Nautilus Biotechnology)?

Matthew Sykes with lowest potential downside - -$0.25

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?